Robert Ross Carter, CFO of Starling Oncology STLN, has filed 1 purchase and 1 sale on the open market. Over the past 12 months that comes to a net sale of $879. The latest trade was on 05/21.

RC

RC

Robert Ross Carter

CFO

Company

Starling Oncology STLN

First filing

24/11/21

Trades

14 trades

Buys / sales

1 / 1

12-month net buying

−$879

Last trade

05/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Starling OncologySTLN	Open-market sale	01/02	01/05	247 sh	$3.56	$879.32	−0.1%
Starling OncologySTLN	Open-market buy	25/03/26	25/03/28	9,056 sh	$1.04	$9,418.24	+29.8%